MIRASOL
MIRASOL: Mirvetuximab Soravtansine vs Investigator’s Choice of Chemotherapy in FRα-High Expression, Platinum-Resistant Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers

Released: June 05, 2023

Activity

Progress
1
Course Completed